🇺🇸 FDA
Patent

US 9670213

Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor

granted A61PA61P1/04A61P1/16

Quick answer

US patent 9670213 (Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor) held by East China University of Science and Technology expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
East China University of Science and Technology
Grant date
Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/04, A61P1/16, A61P17/06, A61P19/02